Considerations for use of ketamine to treat depression in Australia and New Zealand.

Saved in:
Bibliographic Details
Title: Considerations for use of ketamine to treat depression in Australia and New Zealand.
Authors: Bayes, Adam, Dong, Vanessa, Loo, Colleen
Source: Australian & New Zealand Journal of Psychiatry. Nov2019, Vol. 53 Issue 11, p1117-1120. 4p.
Subjects: Ketamine, Mental depression, Drug prescribing, Medical prescriptions, Physician practice patterns, Inappropriate prescribing (Medicine)
Geographic Terms: Australia, New Zealand
Abstract: The article discusses about the considerations for use of ketamine to treat depression in Australia and New Zealand. Topics discussed include different mechanism of action compared to standard antidepressant (AD) medications and N-methyl-Daspartate (NMDA) receptor antagonist; depression refractory to treatment with electroconvulsive therapy (ECT); and a table is also present related to State, territory and country-based regulations relevant to prescribing ketamine for depression.
Database: Psychology and Behavioral Sciences Collection
Description
Abstract:The article discusses about the considerations for use of ketamine to treat depression in Australia and New Zealand. Topics discussed include different mechanism of action compared to standard antidepressant (AD) medications and N-methyl-Daspartate (NMDA) receptor antagonist; depression refractory to treatment with electroconvulsive therapy (ECT); and a table is also present related to State, territory and country-based regulations relevant to prescribing ketamine for depression.
ISSN:00048674
DOI:10.1177/0004867419866510